GLOBUS MEDICAL INC

Insight: Tobin James’ GLOBUS MEDICAL trades reveal strategic rebalancing—buy low, sell high, and exercise options—highlighting potential value in spinal fusion tech.

GMED insider buy: Director Stephen Zarrilli buys 25,000 shares at $53.27 amid a bullish rally, signaling confidence in spine‑fusion growth and future upside.

Globus Medical insider sale by CFO Kyle Kline shows liquidity management, not a confidence hit – investors see balanced buying and selling that keeps share stability high.